Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders

[1]  H. Okano,et al.  Steps towards COVID-19 suppression , 2020, Inflammation and regeneration.

[2]  M. Zhang,et al.  Huzhang Tongfeng Granule Improves Monosodium Urate-Induced Inflammation of Gouty Arthritis Rat Model by Downregulation of Cyr61 and Related Cytokines , 2020, Evidence-based complementary and alternative medicine : eCAM.

[3]  Hans Clevers,et al.  SARS-CoV-2 productively infects human gut enterocytes , 2020, Science.

[4]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[5]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[6]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[7]  A. Verkhratsky,et al.  Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID‐19 , 2020, Acta physiologica.

[8]  J. Guan,et al.  Novel coronavirus and central nervous system. , 2020, European journal of neurology.

[9]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[10]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[11]  Taiwen Li,et al.  High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa , 2020, International Journal of Oral Science.

[12]  Xingyang Xue,et al.  Diarrhea may be underestimated: a missing link in 2019 novel coronavirus , 2020, medRxiv.

[13]  E. Holmes,et al.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.

[14]  Hanzhong Wang,et al.  Zika virus promotes CCN1 expression via the CaMKIIα-CREB pathway in astrocytes , 2020, Virulence.

[15]  H. Okano,et al.  Cell therapy for spinal cord injury using induced pluripotent stem cells , 2019, Regenerative therapy.

[16]  H. Okano,et al.  Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury , 2018, Stem cell reports.

[17]  A. Teixeira,et al.  The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research. , 2017, Current drug targets.

[18]  H. Okano,et al.  Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury , 2016, Stem cell reports.

[19]  Alain Le Coupanec,et al.  Human coronaviruses: Viral and cellular factors involved in neuroinvasiveness and neuropathogenesis , 2014, Virus Research.

[20]  Barbara Corneo,et al.  CORTECON: A Temporal Transcriptome Analysis of In Vitro Human Cerebral Cortex Development from Human Embryonic Stem Cells , 2014, Neuron.

[21]  H. Okano,et al.  Modeling familial Alzheimer's disease with induced pluripotent stem cells. , 2011, Human molecular genetics.

[22]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[23]  E. Chiocca,et al.  Oncolytic HSV-1 infection of tumors induces angiogenesis and upregulates CYR61. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  K. Chung,et al.  Coxsackievirus B3 Infection Induces cyr61 Activation via JNK To Mediate Cell Death , 2004, Journal of Virology.

[25]  T. Shimazaki,et al.  Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. , 2004, Developmental biology.

[26]  Y. S. Tang,et al.  Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement. , 2003, Journal of medicinal chemistry.

[27]  J. Baik,et al.  Expression of Angiogenic Factor Cyr61 during Neuronal Cell Death via the Activation of c-Jun N-terminal Kinase and Serum Response Factor* , 2003, The Journal of Biological Chemistry.

[28]  P. Brown,et al.  Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Luban.  SARS-CoV-2 , 2020 .

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..